Common Contracts
3 similar Amending Agreement contracts by NUCRYST Pharmaceuticals Corp.
EX-10.8 7 c99794a3exv10w8.htm AMENDING AGREEMENTAmending Agreement • May 5th, 2020
[***] indicates that text has been omitted which is the subject of a confidential treatment request. This text has been filed separately with the SEC. Exhibit 10.8 AMENDING AGREEMENT This Amending Agreement is made effective November 3, 2003 BETWEEN: SMITH & NEPHEW, INC. a corporation pursuant to the laws of the State of Delaware, in the United States of America -and- T.J. SMITH & NEPHEW LIMITED a corporation pursuant to the laws of England and Wales (all of the above parties being hereinafter collectively referred to as “S&N”) -and- NUCRYST PHARMACEUTICALS INC. a corporation pursuant to the laws of the State of Delaware, in the United States of America -and- NUCRYST PHARMACEUTICALS CORP. a corporation pursuant to the laws of the Province of Alberta, Canada (the two parties immediately above being hereinafter collectively referred to as “NUCRYST”) Whereas:
ContractAmending Agreement • December 19th, 2005 • NUCRYST Pharmaceuticals Corp. • Pharmaceutical preparations
[***] indicates that text has been omitted which is the subject of a confidential treatment request. This text has been filed separately with the SEC.
AMENDING AGREEMENTAmending Agreement • December 14th, 2005 • NUCRYST Pharmaceuticals Corp. • Pharmaceutical preparations
